Phase Ib trial of durvalumab plus tremelimumab in combination with particle therapy in patients with advanced hepatocellular carcinoma with macrovascular invasion: DEPARTURE trial.
| Autor: | Koroki, Keisuke, Ogasawara, Sadahisa, Makishima, Hirokazu, Wakatsuki, Masaru, Takahashi, Asahi, Kanzaki, Hiroaki, Kobayashi, Kazufumi, Inoue, Masanori, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Kondo, Takayuki, Nakamoto, Shingo, Shiko, Yuki, Ozawa, Yoshihito, Inaba, Yosuke, Kurokawa, Tomoya, Hanaoka, Hideki, Yamada, Shigeru, Kato, Naoya |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement, Vol. 42, p34-34, 15p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|